0000000000136500

AUTHOR

Domingo Orozco-beltran

0000-0002-8231-2635

showing 17 related works from this author

Cohort Profile: Design and methods of the PREDIMED-Plus randomized trial

2019

The PREDIMED (in Spanish: PREvención con DIeta MEDiterránea) primary prevention trial1–3 reported in 2013 that long-term adherence to an energy-unrestricted Mediterranean diet (MedDiet), supplemented with either extra-virgin olive oil (EVOO) or nuts, reduced cardiovascular disease (CVD). PREDIMED showed a 30% relative reduction in the composite cardiovascular primary endpoint (stroke, myocardial infarction or cardiovascular death).2,,3 However, the PREDIMED trial tested only the composition of the diet, but did not test other lifestyle interventions (i.e. energy reduction, increased physical activity (PA) and behavioural modification) frequently applied in the context of the current unprece…

MaleResearch designobesitymedicine.medical_specialtyTime FactorsEpidemiologyHealth StatusMEDLINE030204 cardiovascular system & hematologyDiet MediterraneanRisk Assessmentlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialRisk FactorslawSurveys and QuestionnairesmedicineHumansMulticenter Studies as Topic030212 general & internal medicineAgedRandomized Controlled Trials as TopicEvidence-Based Medicinebusiness.industryGeneral MedicineMiddle AgedPredimedDietCardiovascular DiseasesResearch DesignSpainSample size determinationSample SizeCohortPhysical therapyFemalepredimed trialRisk assessmentbusinessRisk Reduction BehaviorInternational Journal of Epidemiology
researchProduct

La diabetes mellitus y el riesgo cardiovascular. ¿Es necesario el tratamiento integral de la diabetes mellitus tipo 2 y los factores de riesgo cardio…

2010

ResumenLas enfermedades cardiovasculares (CV) son la primera causa de muerte en la población española, tanto en personas diabéticas como no diabéticas. En la diabetes, la enfermedad CV es entre 2 y 4 veces más frecuente, más precoz y más agresiva. Con las medidas actuales se puede llegar a una prevención del ∼50% de la enfermedad CV. Los factores de riesgo CV en la diabetes son la hipertensión arterial (HTA), la dislipemia, el tabaquismo, la obesidad y el sedentarismo. Más del 80% de pacientes con diabetes tipo 2 presenta HTA y dislipemia, y aproximadamente un 15% sigue fumando. Pero menos de un 10% tiene todos estos factores controlados. Aunque la dislipemia es el factor más condicionante …

Riskmedicine.medical_specialtymedicine.medical_treatmentEnfermedad cardiovascularDiseaseType 2 diabetesRiesgoDiabetes tipo 2Internal medicineDiabetes mellitusmedicineCause of deathMedicine(all)business.industryPreventionType 2 diabetesGeneral MedicineAtención primariaCardiovascular diseasePrimary caremedicine.diseaseObesityPrevenciónBlood pressureSmoking cessationbusinessFamily PracticeDyslipidemiaAtención Primaria
researchProduct

Nut Consumptions as a Marker of Higher Diet Quality in a Mediterranean Population at High Cardiovascular Risk

2019

Background: Nut consumption has been associated with improved nutrient adequacy and diet quality in healthy adult populations but this association has never been explored in individuals at high cardiovascular risk. Objective: to assess the associations between consumption of nuts and nutrient adequacy and diet quality in a Mediterranean population at high cardiovascular risk. Design: baseline assessment of nutritional adequacy in participants (n = 6060, men and women, with ages 55&ndash

MaleMediterranean diet030309 nutrition & dieteticsnut consumptionhumanosOverweightDiet Mediterranean0302 clinical medicineRisk FactorsNutsMicronutrientsmediana edad2. Zero hungerMetabolic Syndromeanciano0303 health scienceseducation.field_of_studyNutrition and Dieteticsencuestas de nutricióndietadigestive oral and skin physiologyfood and beveragesdiet qualityMiddle AgedMicronutrientNutrition Surveys3. Good healthestado nutricionalCardiovascular diseasesDietary Reference IntakeCardiovascular DiseasesCuina (Nous)Femalemedicine.symptomCooking (Nuts)lcsh:Nutrition. Foods and food supplynutrient adequacyNutPopulationenfermedades cardiovascularesMediterranean diet cardiovascular risk disease diet quality nut consumption nutrient adequacyNutritional Statuslcsh:TX341-641030209 endocrinology & metabolismArticlecardiovascular risk disease03 medical and health sciencesMediterranean cooking:Ciencias de la Salud::Medicina preventiva [Materias Investigacion]Environmental healthMediterranean dietCuina mediterràniaingesta energéticamedicinefactores de riesgoHumansObesityeducationobesidadAgedbusiness.industryMalalties cardiovascularsmicronutrientesmediterranean dietmedicine.diseaseObesityDietnuecesMetabolic syndromebusinessEnergy IntakeFood Science
researchProduct

Clinical applicability and cost-effectiveness of DIABSCORE in screening for type 2 diabetes in primary care

2017

Aims: To evaluate the applicability and cost-effectiveness of a clinical risk score (DIABSCORE) to screen for type 2 diabetes in primary care patients. Methods: Multicenter cross-sectional study of 10,508 adult no previously diagnosed with diabetes, in 2 Spanish regions (Canary Islands and Valencian Community). The variables comprising DIABSCORE were age, waist to height ratio, family history of diabetes and gestational diabetes. ROC curves were obtained; the diabetes prevalences odds ratios (HbA1c >= 6.5%) between patients exposed and not exposed to DIABSCORE >= 100, and to fasting blood glucose >= 126 mg/dL were calculated. The opinions of both the professionals and the patients concernin…

AdultBlood Glucosemedicine.medical_specialtyCost effectivenessEndocrinology Diabetes and MetabolismCost-Benefit AnalysisType 2 diabetes030204 cardiovascular system & hematologyValencianCost effectiveness03 medical and health sciences0302 clinical medicineEndocrinologyPregnancyInternal medicineDiabetes mellitusInternal MedicinemedicineOdds RatioPrevalenceHumansMass Screening030212 general & internal medicineFamily historyPrimary health careWaist-to-height ratioClinic epidemiologyPrimary Health Carebusiness.industryType 2 diabetesGeneral MedicineOdds ratioMiddle Agedmedicine.diseaselanguage.human_languageGestational diabetesCross-Sectional StudiesDiabetes Mellitus Type 2ROC CurveSpainEmergency medicinelanguageScreeningFemalebusiness
researchProduct

Is the Physician’s Behavior in Dyslipidemia Diagnosis in Accordance with Guidelines? Cross-Sectional Escarval Study

2013

Background: Clinical inertia has been defined as mistakes by the physician in starting or intensifying treatment when indicated. Inertia, therefore, can affect other stages in the healthcare process, like diagnosis. The diagnosis of dyslipidemia requires $ 2 high lipid values, but inappropriate behavior in the diagnosis of dyslipidemia has only previously been analyzed using just total cholesterol (TC). Objectives: To determine clinical inertia in the dyslipidemia diagnosis using both TC and high-density lipoprotein cholesterol (HDL-c) and its associated factors. Design: Cross-sectional. Setting: All health center visits in the second half of 2010 in the Valencian Community (Spain). Patient…

MaleHealth ScreeningNon-Clinical MedicineCross-sectional studyHealth Care ProvidersCardiovascularchemistry.chemical_compoundRisk FactorsOdds RatioPractice Patterns Physicians'Young adultHealth Systems StrengtheningMultidisciplinaryCommunicationQRAtrial fibrillationMiddle AgedCholesterolMedicineFemalelipids (amino acids peptides and proteins)Guideline AdherencePublic HealthResearch ArticleAdultmedicine.medical_specialtyClinical Research DesignScienceCardiologyYoung AdultDiagnostic MedicinePhysiciansInternal medicineDiabetes mellitusmedicineHumansHealth Care QualityAgedDyslipidemiasHealth Care Policybusiness.industryCholesterolCholesterol HDLOdds ratiomedicine.diseaseMiddle ageCross-Sectional StudieschemistrySpainPreventive MedicinebusinessDyslipidemia
researchProduct

Analysis of LDL and HDL size and number by nuclear magnetic resonance in a healthy working population: The LipoLab Study

2020

Background and aim Atherosclerosis is the underlying process in cardiovascular disease (CVD), the first cause of death in developed countries. We aimed to identify people with no known CVD and normal values of LDL-C and HDL-C, but with alterations in the number and size of lipoprotein particles (as measured by nuclear magnetic resonance [NMR]) and to analyse their sociodemographic, clinical and biochemical characteristics. Methods Cross-sectional study in occupational risks prevention centre in Castellon (Spain) in 2017 and 2018, in consecutively recruited adults (18-65 years) with no known CVD. Sociodemographic, clinical and biochemical variables were collected. Lipid profiles were analyse…

AdultMaleMagnetic Resonance SpectroscopyAdolescentLipoproteinsNormal valuesfamily practice030204 cardiovascular system & hematologyLogistic regressionLipoprotein particleYoung Adult03 medical and health scienceschemistry.chemical_compound0302 clinical medicineNuclear magnetic resonancecardiovascular diseaseHumansWorking populationMedicine030212 general & internal medicineAgedCause of deathLDL particlesbusiness.industryCholesterolCholesterol HDLGeneral MedicineMiddle AgedNMRCross-Sectional StudiesBlood pressurechemistrySpainHDL particlesFemalelipids (amino acids peptides and proteins)businessLipoproteinInternational Journal of Clinical Practice
researchProduct

En la identificación del riesgo cardiovascular con el modelo SCORE, ¿se puede recomendar su cálculo indistintamente con colesterol total o índice ate…

2011

Resumen La escala SCORE recomienda indistintamente dos metodos para el calculo del riesgo cardiovascular: uso de colesterol total (CT) o del indice aterogenico (IA). Se evalua la correlacion entre ambos y la concordancia en la identificacion del riesgo cardiovascular elevado. Estudio observacional en poblacion de 40-65 anos. Se calcula el coeficiente de correlacion intraclase (CCI) de acuerdo, el metodo de Bland-Almand (MBA) y el indice Kappa (IK). El CCI intraclase fue de 0,671 (intervalo del confianza [IC] del 95%, 0,413-0,796; p

business.industryMedicineCardiology and Cardiovascular MedicinebusinessHumanitiesRevista Española de Cardiología
researchProduct

Total and Subtypes of Dietary Fat Intake and its Association with Components of the Metabolic Syndrome in a Mediterranean Population at High Cardiova…

2019

Background: The effect of dietary fat intake on the metabolic syndrome (MetS) and in turn on cardiovascular disease (CVD) remains unclear in individuals at high CVD risk. Objective: To assess the association between fat intake and MetS components in an adult Mediterranean population at high CVD risk. Design: Baseline assessment of nutritional adequacy in participants (n = 6560, men and women, 55&ndash

Blood GlucoseMaleMediterranean diethumanosPhysiologyÀcids grassos030204 cardiovascular system & hematologyOverweightDiet Mediterraneanchemistry.chemical_compound0302 clinical medicineRisk Factorsevaluación de riesgosMedicine030212 general & internal medicinemediana edadlípidos2. Zero hungerchemistry.chemical_classificationMetabolic Syndromeeducation.field_of_studyancianoNutrition and Dieteticsdietaresultado del tratamientofood and beveragesMiddle AgedLipidscardiovascular disease risk3. Good healthfat intakeTreatment OutcomeCardiovascular Diseasesdietary fatObesitatFemalemedicine.symptomlcsh:Nutrition. Foods and food supplyPolyunsaturated fatty acidglucosa sanguíneaMediterranean diet cardiovascular disease risk dietary fat fat intake fatty acidsLinoleic acidPopulationdislipidemiasenfermedades cardiovasculareslcsh:TX341-641Risk Assessmentfatty acidsArticle03 medical and health sciencesgrasas dietéticasMediterranean cooking:Ciencias de la Salud::Medicina preventiva [Materias Investigacion]Mediterranean dietCuina mediterràniafactores de riesgoHumansObesitycardiovascular diseaseseducationhiperglucemiaAgedDyslipidemiasbusiness.industryMalalties cardiovascularsHypertriglyceridemiamedicine.diseaseObesityDietary FatsDietCross-Sectional StudieschemistrySpainHyperglycemiaMetabolic syndromebusinessBiomarkersFood Scienceestudios transversalesNutrients
researchProduct

Manejo de la hiperglucemia con fármacos no insulínicos en pacientes adultos con diabetes tipo 2

2019

Resumen: El adecuado tratamiento de la diabetes mellitus tipo 2 (DM2) incluye la alimentación saludable y el ejercicio (150 min/semana) como pilares básicos. Para el tratamiento farmacológico, la metformina es el fármaco de elección inicial, salvo contraindicación o intolerancia; en caso de mal control, se dispone de 8 familias terapéuticas (6 orales y 2 inyectables) como posibles combinaciones. Se presenta un algoritmo y unas recomendaciones para el tratamiento de la DM2. En prevención secundaria cardiovascular se recomienda asociar un inhibidor del cotransportador sodio-glucosa tipo 2 (iSGLT2) o un agonista del receptor de glucagon-like peptide-1 (arGLP1) en pacientes con obesidad. En pre…

Agonistmedicine.medical_specialtymedicine.drug_class030204 cardiovascular system & hematologyOverweight:Phenomena and Processes::Physiological Phenomena::Nutritional Physiological Phenomena::Diet::Diabetic Diet [Medical Subject Headings]GastroenterologyDiabetes tipo 2:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]03 medical and health sciences0302 clinical medicineFármacos antidiabéticos:Diseases::Nutritional and Metabolic Diseases::Metabolic Diseases::Glucose Metabolism Disorders::Hyperglycemia [Medical Subject Headings]Internal medicineDiabetes mellitusmedicineGliclazide030212 general & internal medicineHiperglucemiaContraindicationlcsh:R5-920business.industryAntidiabetic drugs:Diseases::Endocrine System Diseases::Diabetes Mellitus::Diabetes Mellitus Type 2 [Medical Subject Headings]nutritional and metabolic diseases:Psychiatry and Psychology::Behavior and Behavior Mechanisms::Psychology Social::Life Style [Medical Subject Headings]Type 2 diabetesGeneral Medicinemedicine.diseaseSulfonylureaObesityHumanos:Diseases::Nutritional and Metabolic Diseases::Nutrition Disorders::Overnutrition::Obesity [Medical Subject Headings]MetforminHyperglycemia:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Hypoglycemic Agents [Medical Subject Headings]medicine.symptomlcsh:Medicine (General)Family Practicebusinessmedicine.drug
researchProduct

Predictive validity of the risk SCORE model in a Mediterranean population with dyslipidemia.

2019

Background and aims: Cholesterol treatment for the primary prevention of cardiovascular disease is based on cardiovascular risk, as assessed by the SCORE (Systematic COronary Risk Evaluation) scale. This study aimed to assess the predictive value and clinical utility of the SCORE scale for preventing cardiovascular events and all-cause mortality in people with dyslipidemia and no lipid-lowering treatment. Methods: Patients with dyslipidemia and no lipid-lowering treatment were included from the ESCARVAL-RISK cohort. Cardiovascular risk was calculated by means of the SCORE scale. All deaths and cardiovascular events were recorded for up to five years of follow-up. We calculated sensitivity, …

0301 basic medicinePredictive validityAdultMalemedicine.medical_specialtyTime FactorsPopulationHypercholesterolemia030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicinePredictive Value of TestsRisk FactorsInternal medicineDiabetes mellitusSCOREmedicineHumansProspective StudiesRegistrieseducationAgededucation.field_of_studyFramingham Risk Scorebusiness.industryReproducibility of ResultsMiddle Agedmedicine.diseaseCardiovascular diseaseCardiovascular riskPrognosis030104 developmental biologyCardiovascular DiseasesSpainCohortDisease ProgressionFemaleMetabolic syndromeCardiology and Cardiovascular MedicinebusinessDyslipidemiaKidney diseaseAtherosclerosis
researchProduct

Mediterranean diet and quality of life: Baseline cross-sectional analysis of the PREDIMED-PLUS trial

2018

We assessed if a 17-item score capturing adherence to a traditional Mediterranean diet (MedDiet) was associated with better health-related quality of life among older Spanish men and women with overweight or obesity harboring the metabolic syndrome. We analyzed baseline data from 6430 men and women (age 55-70 years) participating in the PREDIMED-Plus study. PREDIMED-Plus is a multi-centre randomized trial testing an energy-restricted MedDiet combined with promotion of physical activity and behavioral therapy for primary cardiovascular prevention compared to a MedDiet alone. Participants answered a 36-item questionnaire about health-related quality of life (HRQoL) and a 17-item questionnaire…

MaleMediterranean dietCross-sectional studyMetabolic disordersSocial Sciencescardiovascular-diseaselaw.invention613 - Higiene en general. Higiene i salut personalEndocrinology0302 clinical medicinepreventionPsychologyPublic and Occupational HealthMental health and psychiatryadherencelcsh:Sciencemediana edadvalidationancianodieta3. Good healthhealth-statusdepressionObesitatDietaEndocrine Disorders03 medical and health sciencesCuina mediterràniaDiabetes MellitusHumansobesidadAgedPhysical activitylcsh:RassociationBiology and Life Sciencesbenefitsmedicine.diseaseObesitymortalityBenefitsAgronomyHealth CareCross-Sectional Studiesphysical-activity questionnairelcsh:QMetabolic syndromeOlder peopleestudios transversalesGerontologycumplimiento del pacienteEmotionshumanoslcsh:Medicine030204 cardiovascular system & hematologyOverweightDiet MediterraneanDieta mediterràniaPersones gransClinical trialsQuality of lifeRandomized controlled triallawPlant ProductsMedicine and Health Sciences030212 general & internal medicine2. Zero hungerMetabolic SyndromeMultidisciplinarysobrepesotratamiento por actividad físicaAgricultureMiddle AgedPhysical-activity questionnaireHealth-statusExercise TherapyQualitat de vidaHypertensionFemalemedicine.symptomResearch ArticleMediterranean cookingMediterranean dietmedicineObesityMortalityNutritionbusiness.industryOverweightMental healthDietSpaincalidad de vidaQuality of LifePatient ComplianceVegetable oilsbusinessCrop ScienceAssaigs clínics
researchProduct

The influence of hemoglobin A1c levels on cardiovascular events and all-cause mortality in people with diabetes over 70 years of age. A prospective s…

2019

Abstract Aim Glycated hemoglobin A1c (HbA1c) is a reliable risk factor of cardiovascular diseases in diabetic patients, but information about this relationship in elderly patients is scarce. The aim of this study is to analyze, the relationship between HbA1c levels and the risk of mayor adverse cardiovascular events (MACE) in patients with diabetes over 70 years. Methods Prospective study of subjects with diabetes using electronic health records from the universal public health system in the Valencian Community, Spain, 2008–2012. We included men and women aged ≥ 70 years with diabetes who underwent routine health examinations in primary care. Primary endpoint was the incidence of MACE: all-…

Malemedicine.medical_specialtyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismPeripheral Arterial Disease03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineDiabetes mellitusDiabetes MellitusInternal MedicineClinical endpointHumansHypoglycemic AgentsMedicineProspective Studiescardiovascular diseases030212 general & internal medicineRisk factorProspective cohort studyStrokeAgedAged 80 and overGlycated HemoglobinNutrition and Dieteticsbusiness.industryIncidence (epidemiology)medicine.diseaseDiabetes Mellitus Type 2Cardiovascular DiseasesHeart failureFemaleFamily PracticebusinessMacePrimary Care Diabetes
researchProduct

Concordancia de las escalas REGICOR y SCORE para la identificación del riesgo cardiovascular alto en la población española

2007

Introduction. The aims of this study were to evaluate the consistency between the SCORE (Systematic Coronary Risk Evaluation) and REGICOR (Registre Gironi del Cor) scales in identifying high cardiovascular risk and to describe the characteristics of those individuals for whom scale results were discrepant. Methods. This cross-sectional study involved 8942 subjects aged 40-65 years who had an indication for a complete lipid profile. The agreement between SCORE (for low-risk countries) and Framingham-REGICOR (with a high risk threshold of 10%) scales in classifying patients as high risk was evaluated using the kappa statistic. Subjects for whom there was a discrepancy between classifications …

medicine.medical_specialtyMultivariate analysismedicine.diagnostic_testbusiness.industryFemale sexLogistic regressionConfidence intervalFasting glucoseCohen's kappaInternal medicinemedicineRisk thresholdCardiology and Cardiovascular MedicineLipid profilebusinessRevista Española de Cardiología
researchProduct

Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study

2018

Introduction The potential impact of targeting different components of an adverse lipid profile in populations with multiple cardiovascular risk factors is not completely clear. This study aims to assess the association between different components of the standard lipid profile with all-cause mortality and hospitalization due to cardiovascular events in a high-risk population. Methods This prospective registry included high risk adults over 30 years old free of cardiovascular disease (2008–2012). Diagnosis of hypertension, dyslipidemia or diabetes mellitus was inclusion criterion. Lipid biomarkers were evaluated. Primary endpoints were all-cause mortality and hospital admission due to coron…

AdultMaleDeath RatesEndocrine Disorderslcsh:MedicineBlood PressureCoronary DiseaseCardiovascular Medicine030204 cardiovascular system & hematologyBiochemistryVascular Medicine03 medical and health sciencesEndocrinology0302 clinical medicinePopulation MetricsRisk FactorsMalalties ComplicacionsMortalitatMedicine and Health SciencesDiabetes MellitusHumans030212 general & internal medicinelcsh:ScienceTriglyceridesSistema cardiovascularAgedMultidisciplinaryPopulation BiologyCholesterol HDLlcsh:RBiology and Life SciencesCorrectionCholesterol LDLMiddle AgedLipidsHospitalizationStrokeCholesterolNephrologyCardiovascular DiseasesMetabolic DisordersHypertensionlipids (amino acids peptides and proteins)Femalelcsh:QBiomarkersResearch ArticlePLOS ONE
researchProduct

Number of drugs used in secondary cardiovascular prevention and late survival in the population of Valencia Community, Spain.

2019

Abstract Background Drug treatment for secondary prevention of cardiovascular disease is recommended by guidelines, but it is not always followed in real life. This study wanted to assess the size of this gap and its impact on mortality in subjects after a cardiovascular event (MACE). Methods Patients with any of MACE in the period from January 1st 2011 to December 31st 2013, and more than one year of follow-up were selected from population of the Valencian Community. Drugs for secondary prevention were antiplatelets, renin-angiotensin system blockers and statins. Assessment of treatment was performed one year after the initial event. Mortality risk was assessed using Cox by the number of d…

DrugMalemedicine.medical_specialtyMedication Therapy Managementmedia_common.quotation_subjectmedicine.medical_treatmentPopulationMyocardial InfarctionAngiotensin-Converting Enzyme InhibitorsDisease030204 cardiovascular system & hematologyRevascularizationRisk Assessment03 medical and health sciencesAngiotensin Receptor Antagonists0302 clinical medicineInternal medicinemedicineSecondary PreventionHumans030212 general & internal medicineMyocardial infarctioneducationStrokemedia_commonAgededucation.field_of_studybusiness.industryConfoundingmedicine.diseaseSurvival AnalysisProfessional Practice GapsStrokeSpainFemaleHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessMacePlatelet Aggregation InhibitorsInternational journal of cardiology
researchProduct

Characterizing Diagnostic Inertia in Arterial Hypertension With a Gender Perspective in Primary Care

2022

Background and ObjectivesSubstantial evidence shows that diagnostic inertia leads to failure to achieve screening and diagnosis objectives for arterial hypertension (AHT). In addition, different studies suggest that the results may differ between men and women. This study aimed to evaluate the differences in diagnostic inertia in women and men attending public primary care centers, to identify potential gender biases in the clinical management of AHT.Study Design/Materials and MethodsCross-sectional descriptive and analytical estimates were obtained nested on an epidemiological ambispective cohort study of patients aged ≥30 years who attended public primary care centers in a Spanish region …

arterial hypertensionequityprimary careArtèriesdiagnostic inertiaMalaltiesgenderDones MalaltiesCardiology and Cardiovascular MedicineFrontiers in Cardiovascular Medicine
researchProduct

Patients' and physicians' preferences for type 2 diabetes mellitus treatments in Spain and Portugal: a discrete choice experiment.

2015

Objective: To assess Spanish and Portuguese patients' and physicians' preferences regarding type 2 diabetes mellitus (T2DM) treatments and the monthly willingness to pay (WTP) to gain benefits or avoid side effects. Methods: An observational, multicenter, exploratory study focused on routine clinical practice in Spain and Portugal. Physicians were recruited from multiple hospitals and outpatient clinics, while patients were recruited from eleven centers operating in the public health care system in different autonomous communities in Spain and Portugal. Preferences were measured via a discrete choice experiment by rating multiple T2DM medication attributes. Data were analyzed using the cond…

:Geographicals::Geographic Locations::Europe::Portugal [Medical Subject Headings]cardiovascular riskHbA1cendocrine system diseases:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Physical Examination::Body Constitution::Body Weights and Measures::Body Mass Index [Medical Subject Headings]:Diseases::Nutritional and Metabolic Diseases::Metabolic Diseases::Glucose Metabolism Disorders::Hypoglycemia [Medical Subject Headings]:Disciplines and Occupations::Health Occupations::Medicine::Public Health [Medical Subject Headings]:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Risk::Risk Factors [Medical Subject Headings]:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]:Named Groups::Persons::Occupational Groups::Health Personnel::Physicians [Medical Subject Headings]HbA(1c)HbA:Diseases::Pathological Conditions Signs and Symptoms::Signs and Symptoms::Body Weight::Body Weight Changes::Weight Loss [Medical Subject Headings]:Diseases::Cardiovascular Diseases [Medical Subject Headings]preferences:Geographicals::Geographic Locations::Europe::Spain [Medical Subject Headings]diabetesnutritional and metabolic diseasesPeso corporalweightPérdida de peso:Health Care::Health Care Facilities Manpower and Services::Health Facilities::Ambulatory Care Facilities [Medical Subject Headings]Diabetes mellitus tipo 2:Diseases::Pathological Conditions Signs and Symptoms::Signs and Symptoms::Signs and Symptoms Digestive::Nausea [Medical Subject Headings]hypoglycemia:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Models Statistical::Logistic Models [Medical Subject Headings]:Diseases::Pathological Conditions Signs and Symptoms::Signs and Symptoms::Body Weight [Medical Subject Headings]:Diseases::Nutritional and Metabolic Diseases::Metabolic Diseases::Glucose Metabolism Disorders::Diabetes Mellitus::Diabetes Mellitus Type 2 [Medical Subject Headings]:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Hypoglycemic Agents [Medical Subject Headings]Enfermedades cardiovascularesHipoglucemiawillingness to pay:Check Tags [Medical Subject Headings]discrete choice model
researchProduct